Retatrutide is an investigational single molecule that activates the body's receptors for three hormones - glucagon, glucose-dependent insulinotropic polypeptide (GIP), and glucagon-like peptide-1 (GLP-1), and is being studied for the treatment of obesity. It employs a triple-agonist (triple-G) mechanism of action. In addition to being a GLP-1RA, it also targets gastric inhibitory polypeptide receptor (GIPR), and glucagon receptor (GCGR). This has consequently shown increased efficacy benefits in clinical trials, superior to those seen with W, which facilitates around -15% body weight loss. Product Name: Retatrutide CAS: 2381089-83-2 Shelf life: 24 months Specification: 5mg/10mg/15mg     x10vials /box Appearance: Lyophilized powder T…

A Video Interactive Platform For Global Opportunities

Copyrights © 2024 aeco-pi.com All Rights.Reserved .